Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial

被引：8

作者：

Khoo, Chee W. ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2010年 / 11卷 / 04期

关键词：

atrial fibrillation; dabigatran; direct thrombin inhibitor; stroke; DESIGN;

D O I：

10.1517/14656560903530691

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oral anticoagulants such as warfarin have been used widely for the treatment of venous thromboembolism and stroke prevention in atrial fibrillation (AF) patients. Warfarin has significant limitations and also requires frequent monitoring. Thus, there is an unmet need, with the quest for alternative oral anticoagulants with stable pharmacokinetics and pharmacodynamics that do not need monitoring. The paper under evaluation provides us with up-to-date information on the safety and efficacy of a new oral anticoagulant, dabigatran, compared with warfarin for stroke prevention in AF patients.</.

引用

页码：685 / 687

页数：3

共 7 条

[1] The pharmacology and management of the vitamin K antagonists [J].

Ansell, J ;

Hirsh, J ;

Poller, L ;

Bussey, H ;

Jacobson, A ;

Hylek, E .

CHEST, 2004, 126 (03) :204S-233S

[2] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[3] Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran [J].

Ezekowitz, Michael D. ;

Connolly, Stuart ;

Parekh, Amit ;

Reilly, Paul A. ;

Varrone, Jeanne ;

Wang, Susan ;

Oldgren, Jonas ;

Themeles, Ellison ;

Wallentin, Lars ;

Yusuf, Salim .

AMERICAN HEART JOURNAL, 2009, 157 (05) :805-810

[4] Clinical trial design issues: At least 10 things you should look for in clinical trials [J].

Glasser, Stephen P. ;

Howard, George .

JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (10) :1106-1115

[5] Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolism [J].

Haas, S .

DRUGS, 2004, 64 (Suppl 1) :7-16

[6] Antithrombotic treatment in real-life atrial fibrillation patients:: a report from the Euro Heart Survey on Atrial Fibrillation [J].

Nieuwlaat, Robby ;

Capucci, Alessandro ;

Lip, Gregory Y. H. ;

Olsson, S. Bertil ;

Prins, Martin H. ;

Nieman, Fred H. ;

Lopez-Sendon, Jose ;

Vardas, Panos E. ;

Aliot, Etienne ;

Santini, Massimo ;

Crijns, Harry J. G. M. .

EUROPEAN HEART JOURNAL, 2006, 27 (24) :3018-3026

[7] The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects [J].

Stangier, Joachim ;

Rathgen, Karin ;

Staehle, Hildegard ;

Gansser, Dietmar ;

Roth, Willy .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (03) :292-303

← 1 →